These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3261062)

  • 1. Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol.
    Simons PJ; Cockshott ID; Douglas EJ; Gordon EA; Hopkins K; Rowland M
    Xenobiotica; 1988 Apr; 18(4):429-40. PubMed ID: 3261062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of [14C]phenol by sheep, pig and rat.
    Kao J; Bridges JW; Faulkner JK
    Xenobiotica; 1979 Mar; 9(3):141-7. PubMed ID: 473790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and metabolism of nateglinide in humans.
    Weaver ML; Orwig BA; Rodriguez LC; Graham ED; Chin JA; Shapiro MJ; McLeod JF; Mangold JB
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):415-21. PubMed ID: 11259325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The disposition and metabolism of [14C]fluconazole in humans.
    Brammer KW; Coakley AJ; Jezequel SG; Tarbit MH
    Drug Metab Dispos; 1991; 19(4):764-7. PubMed ID: 1680653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
    Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The disposition and metabolic fate of 14C-cibenzoline in man.
    Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
    Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and kinetics of amlodipine in man.
    Beresford AP; McGibney D; Humphrey MJ; Macrae PV; Stopher DA
    Xenobiotica; 1988 Feb; 18(2):245-54. PubMed ID: 2967593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of propofol administered as constant rate intravenous infusions in humans.
    Gepts E; Camu F; Cockshott ID; Douglas EJ
    Anesth Analg; 1987 Dec; 66(12):1256-63. PubMed ID: 3500657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
    Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
    Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of 2,4-dinitroaniline in the male F-344 rat.
    Matthews HB; Chopade HM; Smith RW; Burka LT
    Xenobiotica; 1986 Jan; 16(1):1-10. PubMed ID: 3946093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
    Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K
    Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of proton nmr spectroscopy to measure propofol metabolites in the urine of the female Caucasian patient.
    Sneyd JR; Simons PJ; Wright B
    Xenobiotica; 1994 Oct; 24(10):1021-8. PubMed ID: 7900408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disposition of feprazone and its hydroxylated metabolite in human volunteers.
    Berry D; Parke DV
    Xenobiotica; 1988 Jul; 18(7):857-68. PubMed ID: 3176523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.